Table 2.
Comparison of BH4 levels between controls and age- plus gender-matched CFS + OI patients. Results are the mean ± SEM of three independent assays.
| Control | CFS + OI | ||||
|---|---|---|---|---|---|
| Age | Gender | BH4 (ng/mL) | Age | Gender | BH4 (ng/mL) |
| 44 | F | 65.63 ± 4.098 | 49 | F | 138.152 ± 24.332 |
| 44 | M | 112.296 ± 12.113 | 41 | M | 137.053 ± 13.165 |
| 57 | F | 96.841 ± 16.528 | 61 | F | 132.01 ± 18.109 |
| 65 | M | 102.42 ± 9.287 | 56 | M | 109.89 ± 11.98 |
| 64 | F | 67.852 ± 11.121 | 64 | F | 76.494 ± 23.4 |
| 74 | M | 75.669 ± 14.225 | 76 | M | 125.53 ± 4.164 |
| 53 | F | 116.068 ± 8.119 | 56 | F | 132.099± 8.119 |
| 69 | M | 78.222 ± 4.6 | 71 | M | 71.916 ± 12.01 |
| 68 | M | 82.914 ± 23.161 | 66 | M | 113.778 ± 4.33 |
| 22 | F | 31.556 ± 7.110 | 26 | F | 80.444 ± 16.12 |